Baker Tilly Wealth Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-710
Closed -$265K 255
2024
Q2
$265K Sell
710
-1,107
-61% -$374K 0.11% 216
2024
Q1
$630K Buy
1,817
+312
+21% +$118K 0.11% 199
2023
Q4
$689K Buy
1,505
+73
+5% +$36K 0.11% 201
2023
Q3
$697K Sell
1,432
-334
-19% -$157K 0.11% 181
2023
Q2
$790K Buy
1,766
+269
+18% +$135K 0.08% 243
2023
Q1
$727K Sell
1,497
-24
-2% -$11.9K 0.08% 252
2022
Q4
$779K Buy
1,521
+72
+5% +$37.8K 0.1% 233
2022
Q3
$703K Buy
1,449
+11
+0.8% +$5.35K 0.1% 226
2022
Q2
$673K Buy
1,438
+131
+10% +$58.3K 0.09% 246
2022
Q1
$569K Buy
1,307
+83
+7% +$34.7K 0.06% 312
2021
Q4
$568K Buy
1,224
+237
+24% +$105K 0.06% 325
2021
Q3
$384K Buy
987
+209
+27% +$88.7K 0.05% 374
2021
Q2
$344K Buy
778
+167
+27% +$73K 0.06% 367
2021
Q1
$256K Buy
611
+68
+13% +$27.1K 0.05% 396
2020
Q4
$223K Buy
+543
New +$226K 0.07% 299

Other funds holding HUM

Baker Tilly Wealth Management's HUM Position: Q3 2024 in Review

Baker Tilly Wealth Management sold out of Humana (HUM) in Q3 2024, closing a stake of 710 shares — an estimated $265K sold.

Baker Tilly Wealth Management first reported a position in HUM in Q4 2020 and held it in 15 quarters. The position peaked at $790K in Q2 2023. 940 funds tracked by Wall St. Rank hold HUM as of Q3 2024.

  • Baker Tilly Wealth Management reported no remaining Humana position as of Q3 2024 after selling out during the quarter.
  • Baker Tilly Wealth Management sold 710 Humana shares in Q3 2024, an estimated $265K.
  • Baker Tilly Wealth Management first reported a position in Humana in Q4 2020 and held it in 15 quarters.
  • Baker Tilly Wealth Management's Humana position peaked at $790K in Q2 2023.
  • 940 funds tracked by Wall St. Rank held Humana as of Q3 2024.

Based on Baker Tilly Wealth Management's 13F filing for Q3 2024, filed 24 Oct 2024.